The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Protein methyltransferases as a target class for drug discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
A quantitative analysis of kinase inhibitor selectivity
Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1358 · Cited by 2,466
Kleer, C. G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S. A., Ghosh, D., Sewalt, R. G. A. B., Otte, A. P., Hayes, D. F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1933744100 · Cited by 1,649
Epigenetic regulation in psychiatric disorders
Tsankova, N., Renthal, W., Kumar, A., & Nestler, E. J. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2132 · Cited by 1,400
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.
Bracken, A. P., Pasini, D., Capra, M., Prosperini, E., Colli, E., & Helin, K. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg542 · Cited by 1,196
Copeland, R. A. (2005) · PubMed · Cited by 1,092
Self-citationEnzymes: a practical introduction to structure, mechanism, and data analysis
(2001) · Choice Reviews Online · doi:10.5860/choice.38-3881 · Cited by 1,056
New nomenclature for chromatin-modifying enzymes
Allis, C. D., Berger, S. L., Cote, J., Dent, S., Jenuwien, T., Kouzarides, T., Pillus, L., Reinberg, D., Shi, Y., Shiekhattar, R., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.039 · Cited by 957
Tkachuk, D. C., Kohler, S., & Cleary, M. L. (1992) · Cell · doi:10.1016/0092-8674(92)90602-9 · Cited by 920
Reversal of H3K9me2 by a Small-Molecule Inhibitor for the G9a Histone Methyltransferase
Kubicek, S., O'Sullivan, R. J., August, E. M., Hickey, E. R., Zhang, Q., Teodoro, M. L., Rea, S., Mechtler, K., Kowalski, J. A., Homon, C. A., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.017 · Cited by 859
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Simon, J. A., & Lange, C. A. (2008) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2008.07.010 · Cited by 855
The SET-domain protein superfamily: protein lysine methyltransferases.
Dillon, S. C., Zhang, X. Y., Trievel, R. C., & Cheng, X. (2005) · Genome biology · doi:10.1186/gb-2005-6-8-227 · Cited by 843
Gu, Y., Nakamura, T., Alder, H., Prasad, R., Canaani, O., Cimino, G., Croce, C. M., & Canaani, E. (1992) · Cell · doi:10.1016/0092-8674(92)90603-a · Cited by 824
hDOT1L Links Histone Methylation to Leukemogenesis
Okada, Y., Feng, Q., Lin, Y., Jiang, Q., Li, Y., Coffield, V. M., Su, L., Xu, G., & Zhang, Y. (2005) · Cell · doi:10.1016/j.cell.2005.02.020 · Cited by 804
SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
Hamamoto, R., Furukawa, Y., Morita, M., Iimura, Y., Silva, F. P., Li, M., Yagyu, R., & Nakamura, Y. (2004) · Nature Cell Biology · doi:10.1038/ncb1151 · Cited by 731
Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis
Copeland, R. A. (2000) · Wiley eBooks · doi:10.1002/0471220639 · Cited by 726
Self-citationEpigenetic control of T-helper-cell differentiation
Wilson, C. B., Rowell, E., & Sekimata, M. (2009) · Nature Reviews Immunology · doi:10.1038/nri2487 · Cited by 682
H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias
Krivtsov, A. V., Feng, Z., Lemieux, M. E., Faber, J., Vempati, S., Sinha, A. U., Xia, X., Jesneck, J., Bracken, A. P., Silverman, L. B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.001 · Cited by 550
Zhao, Q., Rank, G., Tan, Y. T., Li, H., Moritz, R. L., Simpson, R. J., Cerruti, L., Curtis, D. J., Patel, D. J., Allis, C. D., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1568 · Cited by 535
Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9
Greiner, D., Bonaldi, T., Eskeland, R., Roemer, E., & Imhof, A. (2005) · Nature Chemical Biology · doi:10.1038/nchembio721 · Cited by 521
Arginine methylation regulates the p53 response
Jansson, M., Durant, S. T., Cho, E.-C., Sheahan, S., Edelmann, M., Kessler, B., & La Thangue, N. B. (2008) · Nature Cell Biology · doi:10.1038/ncb1802 · Cited by 462
NUP98–NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis
Wang, G. G., Cai, L., Pasillas, M. P., & Kamps, M. P. (2007) · Nature Cell Biology · doi:10.1038/ncb1608 · Cited by 437
Min, J., Feng, Q., Li, Z., Zhang, Y., & Xu, R.-M. (2003) · Cell · doi:10.1016/s0092-8674(03)00114-4 · Cited by 428
High-resolution genomic profiles of human lung cancer
Tonon, G., Wong, K.-K., Maulik, G., Brennan, C., Feng, B., Zhang, Y., Khatry, D. B., Protopopov, A., You, M. J., Aguirre, A. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504126102 · Cited by 394
Chemical mechanisms of histone lysine and arginine modifications
Smith, B. C., & Denu, J. M. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2008.06.005 · Cited by 390 · cited 1×
“Several putative epigenetic enzymes have recently been identified and, in some cases, their catalytic mechanism and three-dimensional structures have been determine”
BackgroundThe Arginine Methyltransferase CARM1 Regulates the Coupling of Transcription and mRNA Processing
Cheng, D., Côté, J., Shaaban, S., & Bedford, M. T. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.11.019 · Cited by 387
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases
Fedorov, O., Marsden, B., Pogacic, V., Rellos, P., Müller, S., Bullock, A. N., Schwaller, J., Sundström, M., & Knapp, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708800104 · Cited by 359
Li, Y., Reddy, M. A., Miao, F., Shanmugam, N., Yee, J.-K., Hawkins, D., Ren, B., & Natarajan, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802800200 · Cited by 353
Structural and Sequence Motifs of Protein (Histone) Methylation Enzymes
Cheng, X., Collins, R. E., & Zhang, X. (2005) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.34.040204.144452 · Cited by 347
Small Molecule Regulators of Protein Arginine Methyltransferases
Cheng, D., Yadav, N., King, R. W., Swanson, M. S., Weinstein, E. J., & Bedford, M. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401853200 · Cited by 339
Structural Basis for the Product Specificity of Histone Lysine Methyltransferases
Zhang, X., Yang, Z., Khan, S. I., Horton, J. R., Tamaru, H., Selker, E. U., & Cheng, X. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00224-7 · Cited by 329
ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease
Ryu, H., Lee, J., Hagerty, S. W., Soh, B. Y., McAlpin, S. E., Cormier, K. A., Smith, K. M., & Ferrante, R. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606373103 · Cited by 325
Bitoun, E., Oliver, P. L., & Davies, K. E. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl444 · Cited by 312
Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294
Chang, Y., Zhang, X., Horton, J. R., Upadhyay, A. K., Spannhoff, A., Liu, J., Snyder, J. P., Bedford, M. T., & Cheng, X. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1560 · Cited by 308
Novel Agents on the Horizon for Cancer Therapy
Ma, W. W., & Adjei, A. A. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20003 · Cited by 304
Regulation of Estrogen Receptor α by the SET7 Lysine Methyltransferase
Subramanian, K., Jia, D., Kapoor-Vazirani, P., Powell, D. R., Collins, R. E., Sharma, D., Peng, J., Cheng, X., & Vertino, P. M. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.022 · Cited by 290
Unsafe SETs: histone lysine methyltransferases and cancer
Schneider, R., Bannister, A. J., & Kouzarides, T. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02141-2 · Cited by 287
Enhanced SMYD3 expression is essential for the growth of breast cancer cells
Hamamoto, R., Silva, F. P., Tsuge, M., Nishidate, T., Katagiri, T., Nakamura, Y., & Furukawa, Y. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00146.x · Cited by 268
Chemical probes for histone-modifying enzymes
Cole, P. A. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.111 · Cited by 250
Kondo, Y., Shen, L., Ahmed, S., Boumber, Y., Sekido, Y., Haddad, B. R., & Issa, J.-P. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002037 · Cited by 234
Arginine methyltransferase CARM1 is a promoter‐specific regulator of NF‐κB‐dependent gene expression
Covic, M., Hassa, P. O., Saccani, S., Buerki, C., Meier, N. I., Lombardi, C., Imhof, R., Bedford, M. T., Natoli, G., & Hottiger, M. O. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600500 · Cited by 223
Structural and functional analysis of SET8, a histone H4 Lys-20 methyltransferase
Couture, J.-F., Collazo, E., Brunzelle, J. S., & Trievel, R. C. (2005) · Genes & Development · doi:10.1101/gad.1318405 · Cited by 220
High-throughput kinase profiling as a platform for drug discovery
Goldstein, D. M., Gray, N. S., & Zarrinkar, P. P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2541 · Cited by 215
Biological Effects of Inhibitors of S-Adenosylhomocysteine Hydrolase
Chiang, P. K. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00089-2 · Cited by 211
CARM1 Regulates Estrogen-Stimulated Breast Cancer Growth through Up-regulation of E2F1
Frietze, S., Lupien, M., Silver, P. A., & Brown, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1983 · Cited by 205
Hong, H., Kao, C., Jeng, M., Eble, J. N., Koch, M. O., Gardner, T. A., Zhang, S., Li, L., Pan, C., Hu, Z., et al. (2004) · Cancer · doi:10.1002/cncr.20327 · Cited by 204
Marango, J., Shimoyama, M., Nishio, H., Meyer, J. A., Min, D.-J., Sirulnik, A., Martinez-Martinez, Y., Chesi, M., Bergsagel, P. L., Zhou, M.-M., et al. (2008) · Blood · doi:10.1182/blood-2007-06-092122 · Cited by 197
NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15)
Rosati, R., La Starza, R., Veronese, A., Aventin, A., Schwienbacher, C., Vallespi, T., Negrini, M., Martelli, M. F., & Mecucci, C. (2002) · Blood · doi:10.1182/blood.v99.10.3857 · Cited by 195
Collins, R. E., Tachibana, M., Tamaru, H., Smith, K. M., Jia, D., Zhang, X., Selker, E. U., Shinkai, Y., & Cheng, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410483200 · Cited by 189
Angrand, P.-O., Apiou, F., Stewart, A. F., Dutrillaux, B., Losson, R., & Chambon, P. (2001) · Genomics · doi:10.1006/geno.2001.6524 · Cited by 177
Textbook of Drug Design and Discovery
(2016) · CRC Press eBooks · doi:10.1201/9781315371818 · Cited by 175
Nonprocessive methylation by Dot1 leads to functional redundancy of histone H3K79 methylation states
Frederiks, F., Tzouros, M., Oudgenoeg, G., van Welsem, T., Fornerod, M., Krijgsveld, J., & van Leeuwen, F. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1432 · Cited by 172
Lauring, J. D., Abukhdeir, A. M., Konishi, H., Garay, J. P., Gustin, J. P., Wang, Q., Arceci, R. J., Matsui, W. H., & Park, B. H. (2007) · Blood · doi:10.1182/blood-2007-05-088674 · Cited by 162
Functional insights from structures of coactivator‐associated arginine methyltransferase 1 domains
Troffer‐Charlier, N., Cura, V., Hassenboehler, P., Moras, D., & Cavarelli, J. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601855 · Cited by 161
Watanabe, H., Soejima, K., Yasuda, H., Kawada, I., Nakachi, I., Yoda, S., Naoki, K., & Ishizaka, A. (2008) · Cancer Cell International · doi:10.1186/1475-2867-8-15 · Cited by 160
Substrate Specificity and Kinetic Mechanism of Mammalian G9a Histone H3 Methyltransferase
Patnaik, D., Chin, H. G., Estève, P., Benner, J. S., Jacobsen, S. E., & Pradhan, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409604200 · Cited by 152
Majumder, S., Liu, Y., Ford, O. H., Mohler, J. L., & Whang, Y. E. (2006) · The Prostate · doi:10.1002/pros.20438 · Cited by 151
Mechanism of multiple lysine methylation by the SET domain enzyme Rubisco LSMT
Trievel, R. C., Flynn, E. M., Houtz, R. L., & Hurley, J. H. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb946 · Cited by 128
Sawada, K., Yang, Z., Horton, J. R., Collins, R. E., Zhang, X., & Cheng, X. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405902200 · Cited by 127
Trimethylation of Histone H3 Lysine 4 by Set1 in the Lytic Infection of Human Herpes Simplex Virus 1
Huang, J. L., Kent, J. R., Placek, B. J., Whelan, K. A., Hollow, C. M., Zeng, P.-Y., Fraser, N. W., & Berger, S. L. (2006) · Journal of Virology · doi:10.1128/jvi.00169-06 · Cited by 118
Liedtke, M., & Cleary, M. (2009) · Blood · doi:10.1182/blood-2008-12-197061 · Cited by 118
Gene Amplification and Overexpression of PRDM14 in Breast Cancers
Nishikawa, N., Toyota, M., Suzuki, H., Honma, T., Fujikane, T., Ohmura, T., Nishidate, T., Ohe-Toyota, M., Maruyama, R., Sonoda, T., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4111 · Cited by 116
Hassa, P. O., Covic, M., Bedford, M. T., & Hottiger, M. O. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.044 · Cited by 105
Kim, J., Kee, H. J., Choe, N., Kim, S., Eom, G.-H., Baek, H. J., Kook, H. Y., Kook, H., & Seo, S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02130-07 · Cited by 98
Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1)
Purandare, A. V., Chen, Z., Huynh, T., Pang, S., Geng, J., Vaccaro, W. D., Poss, M. A., O’Connell, J. C., Nowak, K., & Jayaraman, L. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.06.026 · Cited by 97
Fiskus, W. C., Buckley, K., Rao, R., Mandawat, A., Yang, Y., Joshi, R., Wang, Y., Balusu, R., Chen, J., Koul, S., et al. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.10.8213 · Cited by 97
Allan, M., Manku, S., Therrien, É., Nguyen, N. N. M., Styhler, S., Robert, M., Goulet, A.-C., Petschner, A. J., Rahil, G., MacLeod, A. R., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.075 · Cited by 94
Chromatin, cancer and drug therapies
Cortez, C. C., & Jones, P. A. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.07.006 · Cited by 92
Chromatin-modifying enzymes as therapeutic targets – Part 1
Keppler, B. R., & Archer, T. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.10.1301 · Cited by 91
Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)
Huynh, T., Chen, Z., Pang, S., Geng, J., Bandiera, T., Bindi, S., Vianello, P., Roletto, F., Thieffine, S., Galvani, A. P., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.04.075 · Cited by 88
Catalytic Roles for Carbon-Oxygen Hydrogen Bonding in SET Domain Lysine Methyltransferases
Couture, J., Hauk, G., Thompson, M. J., Blackburn, G. M., & Trievel, R. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602257200 · Cited by 83
DNA Methylation as a Target for Drug Design
Bender, C. M., Zingg, J.-M., & Jones, P. A. (1998) · Pharmaceutical Research · doi:10.1023/a:1011946030404 · Cited by 80
Chin, H. G., Patnaik, D., Estève, P., Jacobsen, S. E., & Pradhan, S. (2006) · Biochemistry · doi:10.1021/bi051997r · Cited by 76
Enzymatic mechanism and product specificity of SET-domain protein lysine methyltransferases
Zhang, X., & Bruice, T. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801788105 · Cited by 74
Kang, M. Y., Lee, B. B., Kim, Y., Chang, D. K., Park, S. K., Chun, H.-K., Song, S. Y., Park, J., & Kim, D. (2007) · International Journal of Cancer · doi:10.1002/ijc.22953 · Cited by 53
Jeong, S., Lu, H., Cho, W.-K., Park, H. U., Pise-Masison, C. A., & Brady, J. N. (2006) · Journal of Virology · doi:10.1128/jvi.00186-06 · Cited by 38
Cited by
Regulation of chromatin by histone modifications
Bannister, A. J., & Kouzarides, T. (2011) · Cell Research · doi:10.1038/cr.2011.22 · Cited by 6,012
Epigenetic protein families: a new frontier for drug discovery
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
Knutson, S. K., Wigle, T. J., Warholic, N. M., Sneeringer, C. J., Allain, C. J., Klaus, C. R., Sacks, J. D., Raimondi, A., Majer, C. R., Song, J., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1084 · Cited by 776
Self-citationSneeringer, C. J., Scott, M. P., Kuntz, K. W., Knutson, S. K., Pollock, R. M., Richon, V. M., & Copeland, R. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012525107 · Cited by 683
Self-citationByers, L. A., Wang, J., Nilsson, M. B., Fujimoto, J., Saintigny, P., Yordy, J., Giri, U., Peyton, M., Fan, Y. H., Diao, L., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0112 · Cited by 557
Metadata
- Authors
- Copeland, R. A., Solomon, M. E., & Richon, V. M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2009-09
- Volume
- 8
- Issue
- 9
- Pages
- 724-732
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1973059973
- Cited by
- 460
- References
- 79
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.